Penserra Capital Management’s Teladoc Health TDOC Stock Holding History

Penserra Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-683	Closed	-$49K	–	1509
2022 Q1	$49K	Buy	683 +40	+6%	+$2.88K	﹤0.01%	998
2021 Q4	$59K	Sell	643 -16,931	-96%	-$2.02M	﹤0.01%	987
2021 Q3	$2.23M	Buy	17,574 +1,382	+9%	+$201K	0.05%	336
2021 Q2	$2.69M	Buy	16,192 +245	+2%	+$39.7K	0.05%	311
2021 Q1	$2.9M	Buy	15,947 +15,693	+6,178%	+$3.64M	0.05%	283
2020 Q4	$50K	Sell	254 -278	-52%	-$56.5K	﹤0.01%	686
2020 Q3	$115K	Buy	532 +412	+343%	+$87.2K	﹤0.01%	474
2020 Q2	$22K	Sell	120 -855	-88%	-$150K	﹤0.01%	722
2020 Q1	$172K	Buy	+975	New	+$113K	0.01%	469
2019 Q1	–	Sell	-1,680	Closed	-$83K	–	795
2018 Q4	$83K	Buy	+1,680	New	+$103K	0.01%	402

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Penserra Capital Management's TDOC Position: Q2 2022 in Review

Penserra Capital Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 683 shares — an estimated $49K sold.

Penserra Capital Management first reported a position in TDOC in Q4 2018 and held it in 10 quarters. The position peaked at $2.9M in Q1 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

Penserra Capital Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
Penserra Capital Management sold 683 Teladoc Health shares in Q2 2022, an estimated $49K.
Penserra Capital Management first reported a position in Teladoc Health in Q4 2018 and held it in 10 quarters.
Penserra Capital Management's Teladoc Health position peaked at $2.9M in Q1 2021.
551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Penserra Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.